Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation.

Description: Pfizer has made more than its share of value-destroying acquisitions. The pharmaceutical giant’s $15.2 billion purchase of Hospira could reverse that history.


Date: Feb 05, 2015


Questions for discussion:

  • Summarize Pfizer’s M&A history.
  • What’s different this time?
  • Would you be an investor today?

Leave a Reply

Your email address will not be published. Required fields are marked *